Teriparatide: new indication. Fracture prevention in men: no progress.
There is no evidence that teriparatide prevents clinical fractures in men. Adverse effects are frequent. Daily subcutaneous injections and storage conditions are inconvenient.
D017277:Drug Approval; D005060:Europe; D050723:Fractures, Bone / Q000517:prevention & control*; D006801:Humans; D008297:Male; D016032:Randomized Controlled Trials as Topic; D019379:Teriparatide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D019379:Teriparatide